White Paper

Clinically Proven: LipoAvail® Boosts VC & GSH

Overview

LipoAvail® VC & GSH are more than just a boost for your skin’s radiance and antioxidant defense—they are a science-backed brightening solution.

Our human clinical trial proves LipoAvail® liposomal Vitamin C can boost bioavailability by 1.65 times, while liposomal Glutathione achieves 1.38 times higher absorption. Want your body to absorb more nutrients of what you give it? LipoAvail® maximizes nutrient absorption efficiency across various products.

Download the White Paper to learn about nutrition industry trends; Unlock and discover full potential of clinically backed liposomal products.

This content is provided by Effepharm Ltd, and any views and opinions expressed do not necessarily reflect those of NutraIngredients.com

Download Now

Latest Content

NMN supplementation proved to mitigate radiotherapy-induced damages

Paid for and content provided by Effepharm Ltd

Scientific study validates NMN’s efficacy in alleviating intestinal damages caused by radiotherapy through reducing alterations to gut bacteria composition and function.

NMN New Clinical Finding: Obvious NAD(H) Level Increase

Paid for and content provided by Effepharm Ltd

With 7.3% CAGR, The "Nicotinamide Mononucleotide (NMN) Market" size is expected to grow from 194.2 million USD In 2020, to reach 296.5 Million USD by 2026.”